Alnylam Pharmaceuticals Inc (ALNY) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Alnylam Pharmaceuticals Inc   (NASDAQ: ALNY)
 

Alnylam Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Alnylam Pharmaceuticals Inc inventory turnover ratio, the Alnylam Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 11.45 in the second quarter 2026, ALNY's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Alnylam Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 32 days, compare to 35 days, in the Mar 31 2026 quarter.

Within Healthcare sector 32 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 335, from total ranking in the first quarter 2026 at 468.

ALNY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Alnylam Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALNY Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 35.46 % 28.12 % 5.36 % -0.79 % -14.64 %
Y / Y Cost of Sales Growth 110 % 195.68 % 160.81 % 140.58 % 111.13 %
Inventory Turnover Ratio (TTM) 11.45 10.38 9.17 7.04 5.44
ALNY's Total Ranking # 335 # 468 # 468 # 415 #
Average inventory processing period 32 35 40 52 67
Seq. Inventory Growth 15.57 % 1.58 % 9.73 % 5.15 % 9.31 %
Seq. Cost of Sales Growth 43.73 % -22.49 % 35.74 % 38.87 % 102.37 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 33
Overall Market # 335

Inventory Turnover Ratio Statistics
High Average Low
10.38 2.58 0.35
(Mar 31 2026)   (Jun 30 2019)



ALNY Company Profile >> Back to ALNY Efficiency Comparisons >> Compare ALNY Inventory Turnover Ratio to its Competitors

Financial Statements
Alnylam Pharmaceuticals Inc 's Inventories $ 97 Millions Visit ALNY's Balance sheet
Alnylam Pharmaceuticals Inc 's Cost of Revenues TTM $ 971 Millions Visit ALNY's Income Statement
What are ALNY's Sales? Visit ALNY's Sales by Segment

Other Inventory Turnover Ratios
Alnylam Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ALNY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ALNY's Competitors
Inventory Turnover Ratio for ALNY's Suppliers
Inventory Turnover Ratio for ALNY's Customers

You may also want to know
ALNY's Sales Growth Rates ALNY's Pe Price to earnings ratio ALNY's Receivables Turnover Ratio ALNY's Stock Quote
ALNY's Net Income Growth Rates ALNY's Ps Price to Sales ratio ALNY's Sales per Employee ALNY's Asset Turnover Ratio
ALNY's Net Margin ALNY's Pb Price to Book ratio ALNY's Financial Strength Ratios ALNY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Viemed Healthcare Inc   24.71 $ 128.283  Millions$ 5  Millions
Aspira Women s Health inc   22.57 $ 5.988  Millions$ 0  Millions
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Prophase Labs Inc   22.13 $ 2.633  Millions$ 0  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Adapthealth Corp   18.95 $ 2,676.899  Millions$ 141  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Edap Tms Sa  12.79 $ 62.351  Millions$ 5  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions

Date modified: 2026-09-13T23:34:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.